Home > Insider Trading > Filing (0001209191-23-018261)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1839384	T. Erik Engelson	C/O Lucira Health Inc. 1412 62Nd St Emeryville CA 94608	President And Chief Executive	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-03-03	574,666	$0.82	657,948	No	4	M	Direct
Common Stock	Disposition	2023-03-03	574,666	$1.03	83,282	No	4	S	Direct
Common Stock	Disposition	2023-03-03	60,000	$1.09	23,282	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2023-03-03	574,666	$0.00	574,666	$0.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-04-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,400	Indirect	See Footnotes
Common Stock	191,705	Indirect	See Footnotes

Footnotes

The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securitiesexcept to the extent of his pecuniary interest therein.
The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.